Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a couple's lifestyle program reduce prostate cancer disparities?

NCT ID NCT04215029

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a lifestyle program for African American men who have finished prostate cancer treatment and their spouses or partners. The goal is to see if the program can improve quality of life, diet, physical activity, and partner support. Only 6 participants were enrolled, so the main focus is on whether the program is practical and acceptable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

6 people

The number who actually took part.

Started

Aug 2019

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * To be eligible, prostate cancer survivors must self-identify as black or African American * Prostate cancer survivors must have 0-III stage prostate cancer * Prostate cancer survivors must have completed therapy (e.g., surgery, chemotherapy \[chemo\] and/or radiation) * Prostate cancer survivors must enroll with a spouse or a romantic partner * Prostate cancer survivors must not meet physical activity recommendation (i.e., 150 minutes of moderate intensity physical activity per week) * Prostate cancer survivors must be willing and able to be physically active, as determined by responses to the Physical Activity Readiness Questionnaire (PAR-Q) * Prostate cancer survivors must not participate in another physical activity, diet, or lifestyle program * Prostate cancer survivors must have a valid home address and telephone number * Prostate cancer survivors must be able to access internet over a smartphone or a computer at home or other location (e.g., work, church, library, community center, etc.) * To be eligible, spouses or romantic partners must be \>=18 years of age * Spouses or romantic partners must enroll with a spouse or a romantic partner with prostate cancer * Spouses or romantic partners must live together with the survivors * Spouses or romantic partners must not have major health problems (e.g., cancer, dementia, stroke, and heart and lung diseases) * Spouses or romantic partners must be willing and able to be physically active, as determined by responses to the Physical Activity Readiness Questionnaire (PAR-Q) * To be eligible, healthcare providers must be currently providing care with individuals diagnosed with prostate cancer * Any professionals such as surgical and medical oncologists, fellows, nurse practitioners, physical assistants, and primary care physicians will be eligible Exclusion Criteria: * Prostate cancer survivors will be excluded if they are not married or partnered * Prostate cancer survivors will be excluded if they have an active noncutaneous malignancy at any site * Prostate cancer survivors will be excluded if they had a prior history of other cancer or have metastatic cancer * Prostate cancer survivors will be excluded if they have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period * Prostate cancer survivors will be excluded if they are on active surveillance * Prostate cancer survivors will be excluded if they enrolled in a protocol #: 2017-0556 * Prostate cancer survivors will be excluded if they are not able to understand and speak English * Spouses or romantic partners who are not able to understand and speak English will be excluded * Also, spouses or romantic partners who enrolled in a protocol (#2017-0556) will be excluded * There are no exclusion criteria for healthcare providers

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer survivor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.